CEACAM3 and cancer: Serum CEA levels may be monitored to detect a response to anti-cancer therapy, or disease recurrence in colorectal cancer [6], and serves as a prognostic indicator in patients with gastrointestinal cancers, where elevated levels indicate a poor prognosis and correlate with reduced overall survival [7], [8], [9].